ProfessionalLive ClassesNo New Dates

Ayahuasca the Basics for Therapists

This on-demand course introduces clinicians to the foundational elements of ayahuasca, covering its cultural significance, therapeutic uses, pharmacology, and transformative effects.

Provider

Fluence

English

Schedule

2 Hours

Enrollment

$75

Course Overview

The Ayahuasca The Basics for Therapists course provides foundational knowledge for clinicians interested in understanding and integrating ayahuasca experiences into their practice. This program covers the historical, cultural, and pharmacological aspects of ayahuasca, as well as its therapeutic potential and risks. Participants engage in live online sessions, interactive discussions, and case studies to explore the ethical and practical considerations of working with clients who use ayahuasca.

Over several weeks, the course delves into preparation, support during experiences, and post-ceremony integration, emphasizing a holistic and informed approach. Participants will learn about the traditional contexts of ayahuasca use, contemporary applications, and the latest research findings. The course aims to equip therapists with the skills and knowledge to provide effective support to clients incorporating ayahuasca into their therapeutic journey.

By the end of the program, clinicians will have a solid understanding of ayahuasca's role in therapy and be prepared to address the unique challenges and opportunities it presents. This training fosters a comprehensive and culturally sensitive approach to integrating ayahuasca experiences within a therapeutic framework.

Who is this for?

Clinicians and therapists interested in understanding and supporting clients who use ayahuasca.

About the Provider

Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.

Related Courses

View all courses